companies / arterytx-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-02 json
| total_raised | 2,454,5212.5M | ○ |
|---|---|---|
| founded | 2004 | |
| hq | SAN RAMON, California | |
| industry | unknown | |
| stage | null |
Artery Therapeutics, Inc. (ARTERY) is a pre-clinical stage biotechnology company developing effective treatments for neurodegenerative and metabolic diseases. CURING APOE4 ASSOCIATED NEURODEGENERATIVE DISEASES, INCLUDING ALZHEIMER'S DISEASE BY TARGETING THE ABCA1 TRANSPORTER Artery Therapeutics, Inc. (Artery), a. Artery’s novel peptide library i.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2025-01-01 | grant | 2,454,5212.5M | null | ○ |
Google Cloud CDN, Sentry, Partytown, Vercel Speed Insights, WebsiteBuilder, Wix, Google Cloud, React, lodash .
| fact | status | src |
|---|---|---|
| Grant, $2.5M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |